Literature DB >> 2974766

Analysis of negatively charged dye-binding antibodies reactive with double-stranded DNA and heparan sulfate in serum from patients with rheumatic diseases.

S Aotsuka1, M Okawa-Takatsuji, M Kinoshita, R Yokohari.   

Abstract

Antibodies to double-stranded (ds) DNA are characteristically present in serum from patients with systemic lupus erythematosus (SLE). Recently, anti-dsDNA antibodies have been shown to have the capacity to react with a diversity of molecules with repeating negative charges. Using the anionic dye Cibacron blue F3GA, bound to crosslinked agarose, we analysed the nature of antibodies capable of reacting with this dye in serum samples from patients with various rheumatic diseases. The dye-antibody complex could easily be split by eluting with solutions of increasing ionic strength, suggesting that the interaction is ionic in nature. Pepsin-digested F(ab')2 antibodies retained the capacity to bind Cibacron blue, confirming that the binding occurred via antigen-binding sites on the antibody molecule. The eluates obtained from dye-ligand chromatography of active SLE sera contained antibodies to both dsDNA and heparan sulfate, while those of sera from patients with other non-SLE rheumatic diseases contained antibodies only against heparan sulfate. Furthermore, the dye-ligand eluates of sera from patients with active SLE and other non-SLE rheumatic diseases were found to contain increased amounts of IgG. In one patient with SLE, levels of antibodies to dsDNA and heparan sulfate, and the amounts of total IgG in dye-ligand eluates, were shown to be correlated with disease activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2974766      PMCID: PMC1541765     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Immunology of DNA. I. The influence of reaction conditions on the Farr assay as used for the detection of anti-ds DNA.

Authors:  L A Aarden; F Lakmaker; T E Feltkamp
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

2.  Affinity chromatography of phosphofructokinase using Cibacron blue F3G-A.

Authors:  H J Böhme; G Kopperschläger; J Schulz; E Hofmann
Journal:  J Chromatogr       Date:  1972-06-28

3.  Effect of Cibacron blue F3GA on oligonucleotide binding site of estradiol--receptor complexes of mouse uterine cytosol.

Authors:  S A Kumar; T A Beach; H W Dickerman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

4.  Measurement of anti-double-stranded DNA antibodies in major immunoglobulin classes.

Authors:  S Aotsuka; M Okawa; K Ikebe; R Yokohari
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

5.  Anti-double strand (ds) DNA antibody formation by NZB/W (F1) spleen cells in a microculture system detected by solid phase radioimmunoassay.

Authors:  H Okudaira; E Terada; T Ogita; S Aotsuka; R Yokohari
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

6.  Partial purification of anti-DNA antibodies from systemic lupus erythematosus serum by dye-ligand chromatography.

Authors:  K M Pollard; J Webb
Journal:  J Immunol Methods       Date:  1982-10-15       Impact factor: 2.303

7.  A temperature-sensitive single-stranded DNA-binding protein from Escherichia coli.

Authors:  R R Meyer; J Glassberg; J V Scott; A Kornberg
Journal:  J Biol Chem       Date:  1980-04-10       Impact factor: 5.157

8.  Synthesis of IgM, IgG and IgA in rheumatoid arthritis.

Authors:  K Poikonen; M Oka; T Möttönen; I Jokinen; H Arvilommi
Journal:  Ann Rheum Dis       Date:  1982-12       Impact factor: 19.103

9.  Binding of mouse interferon to polynucleotides.

Authors:  J De Maeyer-Guignard; M N Thang; E De Maeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

10.  Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes.

Authors:  P Faaber; T P Rijke; L B van de Putte; P J Capel; J H Berden
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

View more
  12 in total

Review 1.  Lessons about autoantibody specificity in systemic lupus erythematosus from animal models.

Authors:  D I Stott
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

2.  Monocyte-mediated suppression of anti-DNA antibody production in healthy subjects.

Authors:  M Okawa-Takatsuji; S Aotsuka; S Uwatoko; M Kinoshita; R Yokohari
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

3.  Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression.

Authors:  A Kitani; M Hara; T Hirose; M Harigai; K Suzuki; M Kawakami; Y Kawaguchi; T Hidaka; M Kawagoe; H Nakamura
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

4.  Adsorption of anti-dsDNA antibodies by immobilized polyanionic compounds.

Authors:  S Aotsuka; T Funahashi; N Tani; M Okawa-Takatsuji; M Kinoshita; R Yokohari
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

5.  Endothelial cell-binding activity of anti-U1-ribonucleoprotein antibodies in patients with connective tissue diseases.

Authors:  M Okawa-Takatsuji; S Aotsuka; S Uwatoko; M Takaono; K Iwasaki; M Kinoshita; M Sumiya
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

6.  Evidence for direct anti-heparin-sulphate reactivity in sera of SLE patients.

Authors:  K Pirner; A Rascu; W Nürnberg; A Rubbert; J R Kalden; B Manger
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

7.  Antibodies against sulphatide in sera from patients with autoimmune rheumatic diseases.

Authors:  S Aotsuka; M Okawa-Takatsuji; S Uwatoko; R Yokohari; Y Ikeda; G Toda
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

8.  The B cell repertoire in patients with systemic autoimmune diseases: analysis of Epstein-Barr virus (EBV)-inducible circulating precursors that produce autoantibodies against nuclear ribonucleoprotein (nRNP).

Authors:  M Okawa-Takatsuji; S Aotsuka; S Uwatoko; M Sumiya; R Yokohari
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

9.  Cross-reactive rheumatoid factors in rheumatoid arthritis with extra-articular disease.

Authors:  M Kinoshita; S Aotsuka; R Yokohari
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

10.  Production of intracellular and extracellular interleukin-1 alpha and interleukin-1 beta by peripheral blood monocytes from patients with connective tissue diseases.

Authors:  S Aotsuka; K Nakamura; T Nakano; M Kawakami; M Goto; M Okawa-Takatsuji; M Kinoshita; R Yokohari
Journal:  Ann Rheum Dis       Date:  1991-01       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.